Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Viewray Inc Cm ST (VRAY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 603,099
  • Shares Outstanding, K 95,730
  • Annual Sales, $ 34,040 K
  • Annual Income, $ -72,180 K
  • 36-Month Beta 1.10
  • Price/Sales 18.17
  • Price/Cash Flow N/A
  • Price/Book 3.40

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.22
  • Number of Estimates 5
  • High Estimate -0.19
  • Low Estimate -0.28
  • Prior Year -0.38
  • Growth Rate Est. (year over year) +42.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.80 +11.03%
on 11/12/18
7.19 -10.43%
on 11/29/18
-0.19 (-2.87%)
since 11/09/18
3-Month
5.80 +11.03%
on 11/12/18
10.44 -38.31%
on 10/03/18
-3.49 (-35.15%)
since 09/10/18
52-Week
5.80 +11.03%
on 11/12/18
13.21 -51.25%
on 07/25/18
-2.33 (-26.57%)
since 12/08/17

Most Recent Stories

More News
ViewRay® to Present at the 37th Annual J.P. Morgan Healthcare Conference

ViewRay, Inc. (NASDAQ: VRAY) today announced that the Company will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, California. Scott Drake, President and CEO, is scheduled...

JPM : 100.50 (-2.70%)
VRAY : 6.46 (+2.54%)
Report: Exploring Fundamental Drivers Behind Wayfair, TEGNA, Genpact, ViewRay, United States Steel, and Windstream -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Wayfair Inc. (NYSE:W), TEGNA...

TGNA : 12.55 (-1.10%)
W : 105.24 (+0.45%)
G : 28.05 (-1.30%)
X : 20.66 (-3.05%)
VRAY : 6.46 (+2.54%)
WIN : 2.96 (+1.72%)
Rob Fuchs joins ViewRay as Chief Human Resources Officer

ViewRay, Inc. (Nasdaq: VRAY), maker of the world's first and only clinical MRI-guided radiation therapy system, announced today the appointment of Robert M. Fuchs as Chief Human Resources Officer effective...

VRAY : 6.46 (+2.54%)
ViewRay® to Present at 30th Annual Piper Jaffray Healthcare Conference

ViewRay, Inc. (NASDAQ: VRAY) announced today that company management is scheduled to participate in a fireside chat at the 30th Annual Piper Jaffray Healthcare Conference in New York, NY.

VRAY : 6.46 (+2.54%)
ViewRay Reports Third Quarter 2018 Results

ViewRay, Inc. (Nasdaq: VRAY) ("the Company") today announced financial results for the third quarter ended September 30, 2018.

VRAY : 6.46 (+2.54%)
Report: Developing Opportunities within Vitamin Shoppe, Intercept Pharmaceuticals, Viasat, Team, Valvoline, and ViewRay -- Future Expectations, Projections Moving into 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Vitamin Shoppe, Inc (NYSE:VSI),...

VVV : 20.14 (-1.61%)
VSAT : 65.26 (-0.34%)
ICPT : 104.23 (+1.93%)
TISI : 16.19 (-2.23%)
VRAY : 6.46 (+2.54%)
VSI : 5.90 (-8.10%)
ViewRay Announces Conference Call and Webcast of Third Quarter 2018 Financial Results to be Held After Market on November 8, 2018

ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its third quarter 2018 financial results, which will take place after the market close on Thursday, November 8, 2018.

VRAY : 6.46 (+2.54%)
ASTRO 2018 Presentations to Feature Unique Capabilities and Clinical Outcomes of ViewRay's MRIdian Next Generation Cancer Care

ViewRay, Inc. (Nasdaq: VRAY) announced today that the company's MRIdian® and MRIdian Linac - the world's only FDA-cleared MRI-guided radiation therapy systems - will be featured at the Annual Meeting...

VRAY : 6.46 (+2.54%)
ViewRay® to Host Investor & Analyst Meeting at 2018 ASTRO Annual Meeting in San Antonio

ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will hold a meeting for investors and analysts on Monday, October 22, 2018, during the annual meeting of the American Society for Radiation...

VRAY : 6.46 (+2.54%)
ViewRay Appoints Industry Veteran James Alecxih as Chief Commercial Officer

ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, today announced the appointment of James "Jim"...

VRAY : 6.46 (+2.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade VRAY with:

Business Summary

ViewRay Inc. is a medical device company. The company develops advanced radiation therapy technology for the treatment of cancer. MRIdian system provides continuous soft-tissue imaging during treatment. ViewRay Inc. is headquartered in Oakwood Village, Ohio.

See More

Key Turning Points

2nd Resistance Point 6.78
1st Resistance Point 6.54
Last Price 6.46
1st Support Level 6.11
2nd Support Level 5.92

See More

52-Week High 13.21
Fibonacci 61.8% 10.38
Fibonacci 50% 9.51
Fibonacci 38.2% 8.63
Last Price 6.46
52-Week Low 5.80

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar